Takeda Pharmaceutical Company Limited Other Noncurrent Financial Liabilities
Takeda Pharmaceutical Company Limited (TKPHF) had Other Noncurrent Financial Liabilities of JPY 550.90 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:OtherNoncurrentFinancialLiabilities · last filed 2025-06-25
- 2025-03-31: Other Noncurrent Financial Liabilities 550.90B JPY.
- 2024-03-31: Other Noncurrent Financial Liabilities 687.83B JPY.
- 2023-03-31: Other Noncurrent Financial Liabilities 534.27B JPY.
- 2022-03-31: Other Noncurrent Financial Liabilities 468.94B JPY.
| Period end | Other Noncurrent Financial Liabilities | Other Noncurrent Financial Liabilities as first filed |
|---|---|---|
| 2025-03-31 | 550.90B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 687.83B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 534.27B JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 468.94B JPY 20-F · filed 2023-06-28 | |
| 2021-03-31 | 517.68B JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 399.13B JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 240.22B JPY 20-F · filed 2020-06-24 | 235.79B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 91.22B JPY 20-F · filed 2019-06-27 |